Renal Cancer - Results from #5040

Real-world chart review study of adverse events management in patients taking tyrosine kinase inhibitors to treat metastatic renal cell carcinoma August 3, 2017

Renal cell tumors with clear cell histology and intact VHL and chromosome 3p: a histological review of tumors from the Cancer Genome Atlas database August 3, 2017

Comparison of survival for partial vs. radical nephrectomy in young patients with T1a renal cell carcinoma treated at commission on cancer-accredited facilities and influence of comorbidities on treatment choice August 3, 2017

Real-world costs and outcomes in metastatic renal cell carcinoma patients treated by targeted therapies: a cohort study from the French health insurance database August 2, 2017

Components of metabolic syndrome and prognosis of renal cell cancer August 2, 2017

Systemic therapy following metastasectomy for renal cell carcinoma: Using insights from other clinical settings to address unanswered questions August 1, 2017

Early response of C-reactive protein as a predictor of survival in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors August 1, 2017

Medication use and kidney cancer risk: A population-based study. July 31, 2017

Eligibility for phase 3 clinical trials of systemic therapy in real-world patients with metastatic renal cell cancer managed in a rural region July 31, 2017

The Pathology and Molecular Genetics of Sarcomatoid Renal Cell Carcinoma: A Mini-Review July 28, 2017

Angiosarcoma treated successfully with anti-PD-1 therapy - a case report July 28, 2017

Renoprotective Procedures with a Cold Ischemia Time of <60 min Minimize the Deterioration of Kidney Function in Open Nephron-Sparing Surgery for Renal Cell Carcinoma July 28, 2017

Advanced Renal Cell Carcinoma: Role of the Radiologist in the Era of Precision Medicine July 28, 2017

Changes in levels of metabolic pathway gene expression under conditions of clear cell renal carcinoma July 27, 2017

The Emerging Role of Histone Demethylases in Renal Cell Carcinoma July 27, 2017

Robotic Surgery for Renal Cell Carcinoma with Vena Caval Tumor Thrombus July 27, 2017

Outcomes of Patients With Long-Term Treatment Response to Vascular Endothelial Growth Factor-Targeted Therapy for Metastatic Renal Cell Cancer July 26, 2017

Recommendations for the Management of Rare Kidney Cancers July 26, 2017

Serum tissue factor as a biomarker for renal clear cell carcinoma July 25, 2017

Delayed Intervention of Small Renal Masses on Active Surveillance July 25, 2017

Page 253 of 456